Abstract: A pharmaceutical composition comprising an immediate release phase and a sustained release phase of paracetamol is described which has a unique in vitro dissolution profile resulting in advantageous pharmacokinetic properties.

Abstract: Hydroxycitric acid compositions which comprise approximately 14 to 26% by weight of calcium, and approximately 24 to 40% by weight of potassium or approximately 14 to 24% by weight of sodium, or a mixture thereof, each calculated as a percentage of the total hydroxycitric acid content of the composition, together with dietary supplements and food products containing such compositions and methods for utilizing such compositions, dietary supplements and food products to reduce body weight in mammals are disclosed.

Abstract: Methods and products for delivering a medicament or agent to an individual are provided as well as methods for producing the product. The product includes one or more coatings having a medicament or agent. The coatings can further comprise one or more fat-based confectioneries to provide a coated product that has an improved aesthetic and taste appeal to a consumer. The medicament or agent is present within a coating that surrounds a consumable center. By chewing the coated product, the medicament or agent is released from the product within the buccal cavity.

Abstract: Hydroxycitric acid compositions which comprise approximately 14 to 26% by weight of calcium, and approximately 24 to 40% by weight of potassium or approximately 14 to 24% by weight of sodium, or a mixture thereof, each calculated as a percentage of the total hydroxycitric acid content of the composition, together with dietary supplements and food products containing such compositions and methods for utilizing such compositions, dietary supplements and food products to reduce body weight in mammals are disclosed.

Abstract: The present invention relates to a cosmetic composition with a lipophilic continuous phase, in particular a make-up composition, containing flat fibers. The subject of the invention is also a make-up kit containing a first composition comprising a coloring matter and a second composition comprising a lipophilic continuous phase and flat fibers. The subject of the invention is also a cosmetic method or a method for the care of keratinous materials.

Abstract: An effective controlled release pest control composition can use activated carbon as the sole release agent. Liquid pesticide is adsorbed into the interior mesopore and macropore space of the activated carbon. Upon contact with water, the pesticide is slowly displaced from the carbon into the environment for appropriate control. The particulate can be used as is or can be combined with liquid or solid diluents. The particle can be formed into larger composites comprising a granule, a pellet, and an agglomerated particle, etc. A variety of pesticides can be used including insecticides, herbicides, fungicides, growth regulators, etc.

Abstract: Oral formulations of G-2MePE including microemulsions, coarse emulsions, liquid crystals, tablets and encapsulated forms of G-2MePE have improved bioavailability than conventional aqueous formulations. In particular, microparticles, nanoparticles and microemulsions can exhibit great neuroprotective effects after oral administration. In a microemulsion formulation, G-2MePE can nearly completely inhibit cerebral infarction in an animal model of stroke even after the stroke had been initiated. Thus, improved oral formulations can be desirably used to treat a variety of neurodegenerative conditions with improved convenience and improved efficacy.

Abstract: The invention relates to a bioactive fiber product that, as a bioactively effective constituent, contains only one polyester fiber, which is largely or exclusively made of a polyester having links, which are condensed therewith and which contain phosphorous. The bioactive fiber products are suited for all textile products for which antibacterial, fungicidal, acaricidal and similar effects are sought.

Abstract: Hydroxycitric acid compositions which comprise approximately 14 to 26% by weight of calcium, and approximately 24 to 40% by weight of potassium or approximately 14 to 24% by weight of sodium, or a mixture thereof, each calculated as a percentage of the total hydroxycitric acid content of the composition, together with dietary supplements and food products containing such compositions and methods for utilizing such compositions, dietary supplements and food products to reduce body weight in mammals are disclosed.

Abstract: The present invention provides a percutaneous absorption system and a percutaneous absorption method, which have a simple constitution and can realize the easy and continuous percutaneous absorption of medicine even when the medicine is formed of a water-soluble oligomer solution or a high-molecular solution. In the percutaneous absorption system comprising a medicine reservoir portion having a medicine holding portion which holds medicine therein and a support portion for supporting the medicine reservoir portion, the support portion including an adhesive layer and a substrate having medicine non-permeating property, the system is provided with an elastic member for applying pressure to the medicine held in the inside of the medicine reservoir portion, and by breaking the substrate having medicine non-permeating property in the support portion using a mechanical stimulus such as an injection needle or the like, the medicine is released (delivered) at a fixed rate.

Abstract: This disclosure relates to wound care devices which are capable of one-way, directional flow of fluids and contaminants away from the wound site to the opposite side of the wound care device, which functions as a fluid reservoir. This fluid transport mechanism generally aids in reducing wound maceration by removing excess fluid, and potentially even bacteria, and is carried out without loss of physical integrity of the wound care device itself. In addition to providing a unidirectional fluid transport mechanism, the wound care device may contain a topically applied silver-based antimicrobial finish which provides certain levels of antimicrobial agent to the wound in order to clear infection from the wound site and control bacterial growth in the wound care dressing. Exemplary topical antimicrobial finishes include silver ion-releasing compounds.

Abstract: To provide an anionic surfactant powder comprising a polyoxyalkylene ether sulfate which powder has high stability in hard water, high low-temperature solubility and is improved in powder characteristics such as caking characteristics, and a method of producing the anionic surfactant powder. An anionic surfactant powder comprising polyoxyalkylene alkyl ether sulfates in which the average addition mol number of alkylene oxides is 0.05 to 2, wherein the content of the polyoxyalkylene alkyl ether sulfates provided with alkylene oxides added thereto in an amount of 4 mol or more is 30 % by weight or less based on the total anionic surfactant, an anionic surfactant powder further comprising a water-soluble inorganic salt, a method of producing each of these anionic surfactant powders, and a detergent composition and a cement additive comprising these anionic surfactant powders.

Abstract: Disclosed herein is an anhydrous paste for bleaching human keratin fibers, such as hair, comprising at least one peroxygenated salt, at least one alkaline agent, from 15% to 35% by weight of at least one polydecene of formula C10nH[(20n)+2] wherein n ranges from 3 to 9, such as from 3 to 7, relative to the total weight of the paste, and from 0.01% to 10% by weight of at least one gelling agent chosen from hydrophilic fumed silicas, hydrophobic fumed silicas and diblock, triblock, multiblock and radial-block copolymer comprising at least one segment of styrene monomers and at least one segment of monomers chosen from thermoplastic monomers and comonomers, relative to the total weight of the paste.

Abstract: A wet granulated pharmaceutical composition comprising atorvastatin or a pharmaceutically acceptable salt thereof with less than about 5 weight % of an alkaline earth metal salt additive with a disintegrant which provides the atorvastatin with not more than about 3% atorvastatin lactone based on the ratio of lactone peak area compared to the total drug-related peak integrated areas, as well as said wet granulated pharmaceutical composition comprising atorvastatin or a pharmaceutically acceptable salt thereof in combination with at least one other active drug, methods for preparing said compositions, kits for containing such compositions, and a method of treating hypercholesterolemia and/or hyperlipidemia, osteoporosis, benign prostatic hyperplasia (BPH), and Alzheimer's disease using a therapeutically effective amount of the pharmaceutical compositions.

Abstract: The present invention relates to a capsule comprising a core and at least one envelope comprising at least one film-forming polymer, characterized in that it exhibits a total solubilization time for its envelope of less than or equal to 85 s, according to a test A, preferably less than or equal to 80 s, more preferably less than or equal to 70 s. The invention also relates to the method of producing said capsule, and also to the products comprising said capsule, such as the food, pharmaceutical, oral hygiene or cosmetic products.

Abstract: Since conventional high pullulan content shaped products have a low stability to the change of humidity, the object of the present invention is to provide a high pullulan content shaped product having a satisfactory stability to the change of humidity, a process for producing the same, and uses. The present invention solves the above object by establishing high pullulan content shaped product with an improved stability to the change of humidity by incorporating a prescribed amount of ?,?-trehalose into pullulan in preparing the high pullulan content shaped product, and a process for producing the same, and by providing uses of the high pullulan content shaped product obtainable by the process.

Abstract: The present invention relates to a capsule comprising a core and at least one envelope comprising at least one film-forming polymer, characterized in that it exhibits a total solubilization time for its envelope of less than or equal to 85 s, according to a test A, preferably less than or equal to 80 s, more preferably less than or equal to 70 s. The invention also relates to the method of producing said capsule, and also to the products comprising said capsule, such as the food, pharmaceutical, oral hygiene or cosmetic products.

Abstract: The present invention discloses the autoinducer compounds, such as acyl homoserine lactones, acyl homocysteine lactone, acyl thiolactones, furanones or signal peptides, and their use in animal feed additives and animal feeds to improve animal performance.

Abstract: Purification materials with broad spectrum antimicrobial properties and methods and devices for fluid treatment utilizing said materials are provided. The purification materials include biguanide hydrates and bases. A particular composition includes chlorhexidine dihydrate with the chemical formula (C22H30N10Cl2.1.3 H2O), which is useful in water purification applications.

Abstract: A coated material and a process for producing the coated material which includes providing a coating agent comprising yeast cell wall fractions, as a primary constituent, consisting of cell residue of yeast which has been treated with enzymes, optionally subsequently with acidic solution, and water to remove internal soluble cell constituents; and coating a solid material with the coating agent to provide a coating thereon.